It's an exciting time to be part of the Pharma industry's chemical development ecosystem, with new opportunities being created and adopted to accelerate development of new medicines. This is the first in a short series of posts that will focus on the role of predictive, mechanistic modeling in the industry's transformation.
The much-talked about 'Industry 4.0' phenomenon has led to the creation of awkward terms such as 'digitalization' and one positive consequence of the hype is that it has somewhat aligned the goals of senior managers, systems integrators, consulting companies and industry vendors. We especially liked the review by Deloitte that uses the term 'exponential technologies' to group many of the developments that underpin current transformation opportunities:
We'll be highlighting the role of digital design, simulation & integration, technologies that our customers have practiced on a growing scale for nearly twenty years. We expect the rate of growth to increase quite sharply as new developments, like Reaction Lab, make adoption easier and simulation is integrated with other developing technologies.
If the above whets your appetite, watch this space for the next piece in this series.
As always, customers can contact our support team to discuss immediate applications.
The much-talked about 'Industry 4.0' phenomenon has led to the creation of awkward terms such as 'digitalization' and one positive consequence of the hype is that it has somewhat aligned the goals of senior managers, systems integrators, consulting companies and industry vendors. We especially liked the review by Deloitte that uses the term 'exponential technologies' to group many of the developments that underpin current transformation opportunities:
Snapshot of exponential technologies covered in the Deloitte study, Exponential Technologies in Manufacturing |
If the above whets your appetite, watch this space for the next piece in this series.
As always, customers can contact our support team to discuss immediate applications.